0001104659-23-129185.txt : 20231226 0001104659-23-129185.hdr.sgml : 20231226 20231226160523 ACCESSION NUMBER: 0001104659-23-129185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231221 FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rombotis Spiro George CENTRAL INDEX KEY: 0001357396 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 231513359 MAIL ADDRESS: STREET 1: C/O CYCLACEL PHARMACEUTICALS, INC. STREET 2: 200 CONNELL DRIVE, SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER NAME: FORMER CONFORMED NAME: Rombotis Spiro DATE OF NAME CHANGE: 20060324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm2333679-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-12-21 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001357396 Rombotis Spiro George C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 1 1 0 0 President and CEO 0 Common Stock 2023-12-21 4 P 0 6070 3.315 A 68658 D Warrants (right to buy) 3.19 2023-12-21 4 P 0 6070 0 A 2023-12-21 2030-12-21 Common Stock 6070 6070 D The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer. Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant. /s/ Spiro Rombotis 2023-12-26